Navigation Links
AccuGenomics to Attend OneMedForum with Standardized Gene Expression Tests for Leukemia and Lung Cancer
Date:1/6/2012

WILMINGTON, N.C., Jan. 6, 2012 /PRNewswire-iReach/ -- AccuGenomics announced today that it will be attending the upcoming OneMedForum at the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Healthcare Conference. AccuGenomics, founded in 2010, develops and commercializes standardized gene expression tests that accurately diagnose, monitor and guide cancer treatment. Capitalizing on a high growth diagnostic market, the company offers highly differentiated solutions in molecular diagnostics for leukemia and lung cancer.

Standardization sets AccuGenomics apart in gene expression testing. The company's standardized nucleic acid quantification (SNAQ) method streamlines complex molecular diagnostic testing that meets FDA guidelines and facilitates rapid deployment in a variety of laboratory settings. SNAQ allows hundreds of robust qPCR measurements from limited patient samples. It is insensitive to the variations of instruments, laboratories and sample quality. SNAQ technology also enables bench top complex molecular testing of limited and degraded samples. Thus AccuGenomics' quantitative, reproducible and accurate numerical gene expression measurements are unparalleled.

During 2012, AccuGenomics will be pursuing FDA approval for its standardized test for Chronic Myeoloid Leukemia (CML) treatment monitoring, in collaboration with Cancer Genetics, Inc. (CGI), a leader in the personalization of cancer treatment. CGI will offer the test in their CLIA lab as a CLIA approved test in early 2012. It accurately monitors treatment efficiency in CML patients previous diagnosed with a BCR-ABL fusion gene event. CML is not currently curable but can be controlled with established conventional drug therapies in most patients. Accurate measurements of BCR-ABL fusion transcript are critical to managing CML in those patients who have advanced to accelerated and blast phases as a result of poor response to treatment.

"The field of molecular diagnostics has been seeking a broadly applicable method of standardization to facilitate comparability of data across all labs and platforms," said Dr. Nick Lazaridis, President of AccuGenomics. "Our leading-edge diagnostic solutions in oncology fill that need. We look forward to making new strides in gene expression testing in 2012."

# # #
About AccuGenomics
AccuGenomics is a diagnostic company focused on developing standardized molecular diagnostic tests in oncology utilizing its patented technology. These gene expression tests will generate disease specific data that provide accuracy and intrinsic quality control for patient solutions. Additional information: http://www.accugenomics.com.

Media Contact: Manfred Frey AccuGenomics Inc., 910.332.6522, manfred.frey@pareto-equity.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE AccuGenomics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. MedImmune Presents New Data Demonstrating Increased Risk for Medically Attended RSV in Late-Preterm Infants
2. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
3. DATATRAK Attends 13th Annual DIA Workshop in Japan for Clinical Data Management
4. National Ergonomics Expo Sees Immediate 93% Exhibit Space Renewal for 2010; Equipois, Herman Miller, Neutral Posture, REDpoint International Win 2009 Attendees Choice New Product Awards
5. DATATRAK Attends 22nd Annual DIA EuroMeeting in Monaco
6. Winner Medical Group Inc. to Attend the 2010 Brean Murray, Carret & Co. Life Sciences Summit in New York
7. China Sky One Medical to Attend Investment Conferences in May
8. OXIS International, Inc. Announces Its Attendance at the Rodman & Renshaw Annual Global Investment Conference in London, May 16-18, 2010
9. Inverness Medical Innovations to Attend the Citi Global Health Care Conference on May 26, 2010
10. Inverness Medical Innovations to Attend the Jefferies 2010 Global Life Sciences Conference on June 8, 2010
11. Novo Nordisk Announces Resources to Help Support Kids with Diabetes Attending Summer Camp
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... June 26, 2016 Story ... operating models within the health care industry is causing ... efficiency , Deloitte offers a suite of solutions ... issues impacting efficient cost optimization: labor resource analysis, revenue ... services facilitate better outcomes and better economics ...
(Date:6/24/2016)... 24, 2016 ... the addition of the " Global Markets for ... This report focuses on ... updated review, including its applications in various applications. The ... which includes three main industries: pharmaceutical and biotechnology, food ...
(Date:6/24/2016)... 24, 2016 Research and Markets has ... Companion Diagnostic Tests" report to their offering. ... Diagnostics The World Market for Companion Diagnostics ... diagnostics. Market analysis in the report includes the following: ... Vitro Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 24, 2016 , ... Those who have experienced traumatic events may suffer from ... avenues, such as drug or alcohol abuse, as a coping mechanism. To avoid this ... coping following a traumatic event. , Trauma sufferers tend to feel a range of ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile technology, ... , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can be ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... is proud to recognize Dr. Barry M. Weintraub as a prominent plastic surgeon ... beautiful women in the world, and the most handsome men, look naturally attractive. ...
Breaking Medicine News(10 mins):